CBT Group for Adolescents With ADHD: a Randomized Controlled Trial

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

119 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-04-30

Study Completion Date

2014-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is the first randomized controlled study that tests the efficacy of a cognitive-behavioral group therapy (CBT) on adolescents with ADHD who were in pharmacological treatment but still presented persistent symptoms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder

NCT02566824

Attention Deficit Hyperactivity Disorder

UNKNOWN PHASE4

Psychological Group Treatment in Adults With Attention Deficit Hyperactivity Disorder: Development of a Short Cognitive -Behavioral Program

NCT04588181

ADHD

COMPLETED NA

Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder

NCT02937142

Attention Deficit Disorder With Hyperactivity

COMPLETED NA

MAC-cbt Group Therapy for Adults With ADHD

NCT03806569

Psychotherapy

UNKNOWN NA

Long-Term Effects of CBT on Quality of Life in Adults With ADHD

NCT05290311

Attention Deficit Hyperactivity Disorder

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A multicenter, randomized rater-blinded controlled trial was carried out in a sample of 119 adolescents (15-21 years) and was conducted between April 2012- May 2014. Patients were randomly assigned to 12 group manualized cognitive-behavioural group therapy sessions (n=45) or a waiting list control group (N=44). Primary outcomes were assessed by a blind evaluator (ADHD Rating Scale, Clinical Global Impression Scale for Severity, Global Assessment Functioning) before and after treatment as well as by self-report and parent informant ratings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attention Deficit Hyperactivity Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CBT group

This group consist on a combined intervention: CBT group + psychopharmacological treatment. The group program was based on cognitive-behavioral principles and also motivational interviewing techniques to facilitate skills implementation. The treatment comprised 12 manualized sessions with an inattention module and an impulsivity module.

Group Type EXPERIMENTAL

CBT group

Intervention Type BEHAVIORAL

Psychopharmacological treatment

Participants were only visited to monitor their adherence and continuation on medications for ADHD (methylphenidate or atomoxetine) as prescribed by their psychiatrist.

Group Type ACTIVE_COMPARATOR

Psychopharmacological treatment

Intervention Type DRUG

methylphenidate or atomoxetine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychopharmacological treatment

methylphenidate or atomoxetine

Intervention Type DRUG

CBT group

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* DSM-IV ADHD diagnosis
* age between 15 and 21 years
* stabilized doses of medication for ADHD for at least 2 months prior to the study
* agreement not to seek out any other psychiatric or psychological treatment during the study.

Exclusion Criteria

* affective disorders
* anxiety disorders
* psychotic disorders
* personality disorders
* substance use disorders in the past 6 months
* pervasive developmental disorder
* patients with an IQ lower than 85
* patients receiving concurrent psychological interventions.

Minimum Eligible Age

15 Years

Maximum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No